Relationship of estrogen and progesterone receptors to clinical outcome in metastatic endometrial carcinoma: a Gynecologic Oncology Group Study

M Singh, RJ Zaino, VJ Filiaci, KK Leslie - Gynecologic oncology, 2007 - Elsevier
INTRODUCTION: The goal of this study was to explore the relationship between the
expression of hormone receptors in metastatic endometrial tumors and clinical response to …

Prognostic significance of oestrogen receptor alpha (ERα) and beta (ERβ), progesterone receptor A (PR-A) and B (PR-B) in endometrial carcinomas

N Shabani, C Kuhn, S Kunze, S Schulze, D Mayr… - European Journal of …, 2007 - Elsevier
The expression of the classic steroid receptors ERα and PR-A has been correlated with
stage, histological grade and survival in endometrial cancer. Endometrial cancer samples …

Expression of estrogen receptor-alpha and-beta and progesterone receptor-A and-B in a large cohort of patients with endometrioid endometrial cancer

V Jongen, J Briët, R de Jong, K ten Hoor, M Boezen… - Gynecologic …, 2009 - Elsevier
OBJECTIVE: The estrogen receptor (ER)-alpha and-beta and progesterone receptor (PR)-A
and-B were determined in endometrioid endometrial cancer, and their prognostic values …

Estrogen and progesterone receptors in endometrial cancer and their prognostic relevance

W Kleine, T Maier, H Geyer, A Pfleiderer - Gynecologic oncology, 1990 - Elsevier
Three hundred and nine malignant endometrial tumors were biochemically analyzed with
respect to estrogen (ER) and progesterone (PR) receptors. Fifty-seven percent of …

Prognostic significance of progesterone receptor immunohistochemistry in endometrial carcinoma

K Fukuda, M Mori, M Uchiyama, K Iwai, T Iwasaka… - Gynecologic …, 1998 - Elsevier
Objective. The aim of this study was to evaluate the prognostic significance of steroid
hormone receptors in endometrial carcinoma using immunohistochemical staining for …

Prognostic significance of hormone receptors in endometrial cancer

WT Creasman - Cancer, 1993 - Wiley Online Library
Background. Endometrial carcinoma is the most common femalé pelvic genital malignancy.
Many studies suggest that approximately 75% of all endometrial cancers are clinical Stage I …

Estrogen and progestin receptor levels as prognosticators for survival in endometrial cancer

JT Chambers, N MacLusky, A Eisenfield, EI Kohorn… - Gynecologic …, 1988 - Elsevier
The survival of 213 postmenopausal patients with primary endometrial cancer was analyzed
as a function of clinicopathologic features and cytosol steroid receptor levels. Estrogen …

Tamoxifen and endometrial carcinoma: alterations in estrogen and progesterone receptors in untreated patients and combination hormonal therapy in advanced …

JA Carlson Jr, JC Allegra, TG Day Jr… - American journal of …, 1984 - Elsevier
Estrogen receptors and progesterone receptors were measured in tumors from patients with
previously untreated endometrial carcinoma before and after a 5-day course of tamoxifen …

Estrogen receptor status, determined by immunohistochemistry, as a predictor of the recurrence of stage I endometrial carcinoma

PA Gehrig, L Van Le, B Olatidoye, J Geradts - Cancer, 1999 - Wiley Online Library
BACKGROUND The aim of this study was to compare the concordance between
immunohistochemical (IHC) and biochemical (RIA) methods for determining hormone …

[HTML][HTML] Estrogen receptor, progesterone receptor, and HER2 receptor markers in endometrial cancer

C Wang, DA Tran, MZ Fu, W Chen, SW Fu, X Li - Journal of Cancer, 2020 - ncbi.nlm.nih.gov
Background: Endometrial cancer (EC) is a major gynecologic adenocarcinoma that arises
from the endometrium. While the incidence of EC is on the rise worldwide, survivorship and …